<DOC>
	<DOCNO>NCT01825395</DOCNO>
	<brief_summary>To learn effect 3 , 4-Diaminopyridine ( 3,4-DAP ) patient diagnose Lambert-Eaton myasthenic syndrome ( LEMS ) .</brief_summary>
	<brief_title>Use 3,4-Diaminopyridine Treatment Lambert-Eaton Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Lambert-Eaton Myasthenic Syndrome</mesh_term>
	<mesh_term>3,4-diaminopyridine</mesh_term>
	<mesh_term>4-Aminopyridine</mesh_term>
	<criteria>Age 18 year old , Diagnosed LEMS , If female , negative pregnancy test , If premenopausal , willing practice effective form birth control study , Tested find ECG prolong QT syndrome , Agree second ECG time peak drug effect , Has understood sign Informed Consent . Is known sensitivity 3 , 4DAP , Has history : 1. past current seizure , 2. cardiac arrhythmia , 3. hepatic , renal hematologic disease , 4. severe asthma , Is believe investigator unable comply protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>